PHP

Parkman Healthcare Partners Portfolio holdings

AUM $864M
1-Year Est. Return 33.7%
This Quarter Est. Return
1 Year Est. Return
+33.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$843M
AUM Growth
+$92.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
109
New
Increased
Reduced
Closed

Top Buys

1 +$22.7M
2 +$21.5M
3 +$19.6M
4
UNH icon
UnitedHealth
UNH
+$15.8M
5
RVTY icon
Revvity
RVTY
+$14.8M

Top Sells

1 +$29.2M
2 +$20.3M
3 +$20M
4
GILD icon
Gilead Sciences
GILD
+$17.5M
5
BSX icon
Boston Scientific
BSX
+$11.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
1
Insulet
PODD
$22.9B
$34.3M 4.07%
130,514
+4,753
CVS icon
2
CVS Health
CVS
$105B
$33.7M 3.99%
496,736
+316,736
LLY icon
3
Eli Lilly
LLY
$741B
$32.4M 3.84%
39,191
+11,028
SYK icon
4
Stryker
SYK
$147B
$28.9M 3.43%
77,690
-27
THC icon
5
Tenet Healthcare
THC
$19.1B
$28.7M 3.4%
213,418
+106,431
BDX icon
6
Becton Dickinson
BDX
$53.6B
$27.6M 3.27%
120,283
+49,879
COO icon
7
Cooper Companies
COO
$14.5B
$26.4M 3.13%
312,650
+38,081
UNH icon
8
UnitedHealth
UNH
$331B
$26.3M 3.12%
50,213
+30,213
GILD icon
9
Gilead Sciences
GILD
$149B
$24.5M 2.91%
218,950
-155,875
BSX icon
10
Boston Scientific
BSX
$152B
$22.8M 2.7%
225,990
-111,364
ZBH icon
11
Zimmer Biomet
ZBH
$20.4B
$22.7M 2.69%
+200,500
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$10.1B
$19.6M 2.32%
+277,252
NBIX icon
13
Neurocrine Biosciences
NBIX
$14.8B
$18.6M 2.21%
168,382
+52,655
ALNY icon
14
Alnylam Pharmaceuticals
ALNY
$62.7B
$18.6M 2.21%
68,938
+30,266
TVTX icon
15
Travere Therapeutics
TVTX
$2.65B
$17.1M 2.03%
954,071
-163,721
KNSA icon
16
Kiniksa Pharmaceuticals
KNSA
$3.01B
$16.9M 2.01%
762,621
-2,832
VRNA
17
DELISTED
Verona Pharma
VRNA
$16.5M 1.96%
260,421
-460,236
RXST icon
18
RxSight
RXST
$354M
$15.9M 1.89%
631,238
+330,540
CVRX icon
19
CVRx
CVRX
$270M
$15M 1.78%
1,229,522
+308,348
MCK icon
20
McKesson
MCK
$101B
$14.9M 1.76%
22,101
-899
RVTY icon
21
Revvity
RVTY
$11.3B
$14.8M 1.75%
+139,557
EW icon
22
Edwards Lifesciences
EW
$47.4B
$14.6M 1.73%
200,819
+55,605
QGEN icon
23
Qiagen
QGEN
$10.5B
$14.4M 1.71%
359,644
+90,074
VRDN icon
24
Viridian Therapeutics
VRDN
$2.1B
$14.3M 1.7%
1,064,506
-23,128
PTCT icon
25
PTC Therapeutics
PTCT
$5.33B
$14.3M 1.69%
280,314
+102,946